We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Last week was mixed for Wall Street though the S&P 500, the Dow Jones and the Nasdaq lost about 2.3%, 2.4% and 1.66%, respectively. While fears of a second wave of virus contagion amid reopening of economies and Fed Chair Jerome Powell’s warning about prolonged economic weakness weighed on the markets, higher risk-on sentiments led to gains at the end of the week (read: Inverse ETFs Gain on Powell's Economic Warning).
Biotech and pharma stocks remained steady on developments in COVID-19 drugs and vaccines. Notably, last week, Novavax (NVAX - Free Report) received the largest-ever investment from Coalition for Epidemic Preparedness Innovations (CEPI), a global coalition supporting COVID-19 vaccine development. As a result, the stock gained massively and acted as the cornerstone for the entire industry. Bank stocks rose on merger speculation (read: Bank ETFs Rise on Merger Speculations).
Energy stocks also held steady last week on economic reopening and cues of pickup in activities. And the momentum in the tech sector lasted. Against this backdrop, we highlight a few leveraged ETFs that won big time last week.
VelocityShares 3X Long Silver ETN ) – Up 25.7%
USLV is a 3x leveraged product intended for single-day bets on the silver market, not for long-term allocation. Its linked index is an "excess return" silver index, meaning USLV's returns reflect both the price changes on its futures contracts as well as any gain or loss from "rolling" those futures contracts.
Direxion Daily Junior Gold Miners Index Bull 2X Shares (JNUG - Free Report) ) – Up 12.9%
JNUG provides leveraged exposure (3x) to the Market Vectors Junior Gold Miners Index—a market-cap-weighted index of global gold mining companies that derive at least 50% of their revenue from gold or silver mining activities.
VelocityShares Daily 4x Long USD Vs GBP ETN – Up 9.7%
The product seeks to track the daily performance of the VelocityShares Daily 4X Long USD vs. GBP Index. The index is designed to provide 4 times leveraged exposure, reset daily, to changes in the spot exchange rate between the U.S. dollar and the GBP.
The product seeks daily investment results that correspond to two times (2x) the daily performance of the Bloomberg WTI Crude Oil Subindex.The underlying Bloomberg WTI Crude Oil Subindex is intended to reflect the crude oil segment of the commodities market. The index consists of futures contracts on crude oil only (read: Oil Price Rebound, USO ETF & More).
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Leveraged ETFs of Last Week
Last week was mixed for Wall Street though the S&P 500, the Dow Jones and the Nasdaq lost about 2.3%, 2.4% and 1.66%, respectively. While fears of a second wave of virus contagion amid reopening of economies and Fed Chair Jerome Powell’s warning about prolonged economic weakness weighed on the markets, higher risk-on sentiments led to gains at the end of the week (read: Inverse ETFs Gain on Powell's Economic Warning).
Biotech and pharma stocks remained steady on developments in COVID-19 drugs and vaccines. Notably, last week, Novavax (NVAX - Free Report) received the largest-ever investment from Coalition for Epidemic Preparedness Innovations (CEPI), a global coalition supporting COVID-19 vaccine development. As a result, the stock gained massively and acted as the cornerstone for the entire industry. Bank stocks rose on merger speculation (read: Bank ETFs Rise on Merger Speculations).
Energy stocks also held steady last week on economic reopening and cues of pickup in activities. And the momentum in the tech sector lasted. Against this backdrop, we highlight a few leveraged ETFs that won big time last week.
VelocityShares 3X Long Silver ETN ) – Up 25.7%
USLV is a 3x leveraged product intended for single-day bets on the silver market, not for long-term allocation. Its linked index is an "excess return" silver index, meaning USLV's returns reflect both the price changes on its futures contracts as well as any gain or loss from "rolling" those futures contracts.
Direxion Daily Junior Gold Miners Index Bull 2X Shares (JNUG - Free Report) ) – Up 12.9%
JNUG provides leveraged exposure (3x) to the Market Vectors Junior Gold Miners Index—a market-cap-weighted index of global gold mining companies that derive at least 50% of their revenue from gold or silver mining activities.
VelocityShares Daily 4x Long USD Vs GBP ETN – Up 9.7%
The product seeks to track the daily performance of the VelocityShares Daily 4X Long USD vs. GBP Index. The index is designed to provide 4 times leveraged exposure, reset daily, to changes in the spot exchange rate between the U.S. dollar and the GBP.
Direxion Daily S&P Biotech Bull (LABU - Free Report) – Up 8.5%
The fund gives 300% of the performance of the S&P Biotechnology Select Industry Index (read: 6 Leveraged ETFs Up At Least 25% Last Week).
ProShares Ultra Bloomberg Crude Oil (UCO - Free Report) – Up 7.1%
The product seeks daily investment results that correspond to two times (2x) the daily performance of the Bloomberg WTI Crude Oil Subindex.The underlying Bloomberg WTI Crude Oil Subindex is intended to reflect the crude oil segment of the commodities market. The index consists of futures contracts on crude oil only (read: Oil Price Rebound, USO ETF & More).
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>